Skip to main content
. Author manuscript; available in PMC: 2021 Mar 25.
Published in final edited form as: Fatigue. 2021 Feb 2;8(4):226–244. doi: 10.1080/21641846.2021.1876613

Table 4.

Frequencies of CD16A F/F homozygosity

Populations Number donors % F/F 95% confidence limits+
F/F F/V or V/V All
CFS patients 10 1 11 90.9 58.7–99.8%
Non-CFS family members 18 4 22 81.8 59.7 –94.8%
Unrelated healthy donors 3 13 16 18.8 4–45.6%
CFS family parents, highest possible %F/F# 8 2 10 80@ 44.4–97.5%
CFS family parents, lowest possible %F/F# 5 5 10 50.0 18.7–81.3%
Reference Group: Northern European origin^ 385 534 919 41.9 38.7–45.2%
+

Binomial “exact” calculations of the confidence intervals for proportions

#

Ten CFS family parents: living 5 F/F, 2 F/V, and 0 V/V; 3 deceased.

@

P <0.05, for 8 or more F/F, calculated with 0.419 as the probability that a parent will be F/F.

^

From reference (40); the FCGR3A allele encoding V158 CD16A had a frequency of 0.363.